search
InSight Crime
Trends
- 1Harlan Coben Discusses Final Twist Season 2 Craft▼Harlan Coben’s ‘Final Twist’ Season 2 Interview | True Crime Series Craft for TV Writers
Harlan Coben, the bestselling thriller author behind numerous Netflix adaptations, has given an interview about season 2 of his true crime series 'Final Twist', focused on how the show is crafted and what TV writers can learn from its approach to suspense and plotting. The conversation is aimed at screenwriters interested in adapting crime storytelling for television.
- 2Jo Martin Answers Marlow Murder Club Fan Questions▼The Marlow Murder Club's Jo Martin Answers Fan Questions | Masterpiece | Official Site
Jo Martin, star of the PBS Masterpiece mystery series The Marlow Murder Club, has answered questions submitted by fans in a new feature on the show's official site. The piece offers viewers behind-the-scenes insight into the crime drama, which follows a group of amateur sleuths solving murders in the town of Marlow. Fans of the series are engaging with the cast Q&A as interest in the show continues.
- 3CJNG Leader 'R1' Arrest Exposes Cartel Command Network●R1’s Arrest Exposes the CJNG’s Network of ‘R’ Commanders
Mexican authorities' arrest of the CJNG commander known as 'R1' has laid bare the cartel's system of 'R'-designated leaders who run operations across Mexico and abroad. Reporting by InSight Crime details how figures such as Rubén Oseguera González illustrate how the Jalisco New Generation cartel delegates territorial control to a network of trusted commanders bearing the 'R' designation.
- 4Nathan Fielder's Elizabeth Holmes Documentary Premieres at NYFF▼Nathan Fielder’s Elizabeth Holmes Documentary Holds a Raucous and Revealing NYFF Screening
Nathan Fielder's documentary about disgraced Theranos founder Elizabeth Holmes screened at the New York Film Festival, drawing a lively, packed audience and early press attention. The Hollywood Reporter described the screening as raucous and revealing, suggesting the film offers new insight into Holmes and the fraud that toppled her blood-testing startup.